期刊文献+

竹节参皂苷Ⅳa抑制THP-1源性巨噬细胞泡沫化的研究 被引量:7

Chikusetsu saponinⅣa mitigate foam production of THP-1 derived macrophages
原文传递
导出
摘要 目的研究竹节参皂苷Ⅳa(CsⅣa)抑制THP-1源性巨噬细胞泡沫化的作用机制。方法培养THP-1源性巨噬细胞,分为对照组、模型组和低、高剂量实验组。对照组常规培养,模型组细胞用50μg·mL^(-1)氧化低密度脂蛋白(ox-LDL)处理,低、高剂量实验组分别用25,50μmol·L^(-1)的CsⅣa处理1 h,再用50μg·mL^(-1)ox-LDL处理。用细胞计数法-8(CCK-8)检测THP-1源性泡沫细胞活力,用油红O法检测巨噬细胞泡沫化程度,用酶联免疫吸附(ELISA)法检测肿瘤坏死因子-α(TNF-α)和白细胞介素-1β(IL^(-1)β)水平,用逆转录聚合酶链反应(RT-PCR)法检测微管相关蛋白轻链3(LC3)、p62、Beclin1、TNF-α、IL^(-1)β的mRNA水平,用蛋白质印迹法检测LC3、p62、Beclin1蛋白水平。结果对照组、模型组和低、高剂量实验组TNF-α分别为(0.68±0.07),(1.24±0.13),(0.95±0.05)和(0.80±0.03)pg·mL^(-1),IL^(-1)β为(1.60±0.09),(2.14±0.14)和(1.90±0.16),(1.73±0.13)pg·mL^(-1),Beclin 1蛋白表达水平分别为1.48±0.09,0.83±0.07,1.45±0.05和1.62±0.19,p62蛋白表达水平分别为0.52±0.07,0.82±0.08,0.72±0.04和0.41±0.04,LC3Ⅱ/Ⅰ蛋白表达水平分别为3.12±0.23,3.06±0.25,3.66±0.42和4.05±0.23。以上数据,模型组与对照组相比,差异均有统计学意义(均P<0.05),低、高剂量实验组与模型组相比,差异均有统计学意义(均P<0.05)。结论CsⅣa治疗动脉粥样硬化的作用机制可能与促进巨噬细胞自噬、抑制泡沫化的发生、降低炎性因子有关。 Objective To investigate the mechanism of Chikuseksu saponinⅣa(CsⅣa)inhibiting the foam of THP-1 derived macrophages.Methods THP-1-derived macrophages were cultured,divided into control group,model group and low,high dose experimental groups.Control group was conventionally cultured;model group was treated with oxidized low-density lipoprotein(ox-LDL);low,high dose experimental groups were treated with 25,50μmol·L^(-1) CsⅣa for 1 h,and then treated with 50μg·mL^(-1) ox-LDL.Cell counting kit-8(CCK-8)was used to detect the viability of THP-1 derived foam cells.The level of macrophage foam was detected by oil red O;enzyme-linked immunosorbent assay(ELISA)was used to detect the secretion levels of tumor necrosis factor-α(TNF-α)and interleukin-1β(IL^(-1)β).Reverse transcription-polymerase chain reaction(RT-PCR)was used to detect the mRNA levels of microtubule-associated protein light chain 3(LC3),p62,Beclin-1,TNF-αand IL^(-1)β.Western blot was used to detect the protein levels of LC3,p62 and Beclin-1.Results TNF-αlevels in control group,model group and low,high dose experimental groups were(0.68±0.07),(1.24±0.13),(0.95±0.05),(0.80±0.03)pg·m L^(-1),IL^(-1)βlevels were(1.60±0.09),(2.14±0.14),(1.90±0.16),(1.73±0.13)pg·m L^(-1);Beclin 1 protein expression levels were 1.48±0.09,0.83±0.07,1.45±0.05,1.62±0.19;p62 protein expression levels were 0.52±0.07,0.82±0.08,0.72±0.04,0.41±0.04;LC3Ⅱ/Ⅰprotein expression levels were 3.12±0.23,3.06±0.25,3.66±0.42,4.05±0.23,respectively.In the above data,there were statistically significant differences between model group and control group(all P<0.05),and between low,high dose experimental groups and model group(all P<0.05).Conclusion The mechanism of CsⅣa in the treatment of atherosclerosis may be related to promoting macrophage autophagy,inhibiting the foaming of foam and reducing inflammatory factors.
作者 袁林 梁晓晓 罗颖 夏燕 冯佳 田瑞 张莉 汪莲开 YUAN Lin;LIANG Xiao-xiao;LUO Ying;XIA Yan;FENG Jia;TIAN Rui;ZHANG Li;WANG Lian-kai(Hubei Key Laboratory of Occurrence and Intervention of Rheumatic Diseases,Hubei University for Nationalities,Enshi 445000,Hubei Province,China;Department of Cardiology,Affiliated Hospital of Hubei University for Nationalities,Enshi 445000,Hubei Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2022年第10期1051-1054,共4页 The Chinese Journal of Clinical Pharmacology
基金 湖北省卫健委基金资助项目(WJ2019H139) 恩施州科技局基金资助项目(2018-10)。
关键词 竹节参皂苷Ⅳa 自噬 炎症 动脉粥样硬化 Chikusetsu saponinⅣa autophagy inflammation atherosclerosis
  • 相关文献

参考文献10

二级参考文献72

共引文献85

同被引文献97

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部